Literature DB >> 30983204

[Progress of research on the relationship between calcitonin gene-related peptide and RANK/RANKL/OPG system in the bone reconstruction].

Shiyao Wang1, Shaoce Xu1, Zhengwei Shi1, Jianchao Wu1, Shuanhu Lei2, Yuliang Wang3.   

Abstract

OBJECTIVE: To summarize the research progress on the calcitonin gene-related peptide (CGRP) and receptor activator of nuclear factor κB (RANK)/receptor activator of nuclear factor κB ligand (RANKL)/osteoprotegerin (OPG) system during bone reconstruction to provide theoretical basis for further research on the prevention and treatment of bone-related diseases.
METHODS: The relevant research results at home and abroad in recent years were analyzed and summarized.
RESULTS: CGRP and RANK/RANKL/OPG system play important regulatory roles in the bone reconstruction.
CONCLUSION: At present, the research on the mechanism of CGRP and RANK/RANKL/OPG system in bone reconstruction is insufficient. Therefore, it is necessary to study further on the process and interrelation of CGRP and RANK/RANKL/OPG system in bone reconstruction to confirm their mechanism, which will bring new ideas and methods for the treatment of bone related diseases in clinic.

Entities:  

Keywords:  Bone reconstruction; calcitonin gene-related peptide; osteoblast; osteoclast; osteoprotegerin; receptor activator of nuclear factor κB; receptor activator of nuclear factor κB ligand

Mesh:

Substances:

Year:  2019        PMID: 30983204      PMCID: PMC8337187          DOI: 10.7507/1002-1892.201811137

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  38 in total

1.  Galectin-3 is essential for proper bone cell differentiation and activity, bone remodeling and biomechanical competence in mice.

Authors:  Carla Iacobini; Claudia Blasetti Fantauzzi; Rossella Bedini; Raffaella Pecci; Armando Bartolazzi; Bruno Amadio; Carlo Pesce; Giuseppe Pugliese; Stefano Menini
Journal:  Metabolism       Date:  2018-02-09       Impact factor: 8.694

2.  Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane.

Authors:  E A O'Brien; J H Williams; M J Marshall
Journal:  Bone       Date:  2001-02       Impact factor: 4.398

3.  Establishment of a new murine model of hypercalcemia with anorexia by overexpression of soluble receptor activator of NF-κB ligand using an adenovirus vector.

Authors:  Tetsuro Enomoto; Yuriko Furuya; Yoshiya Tomimori; Kaoru Mori; Jun-ichi Miyazaki; Hisataka Yasuda
Journal:  J Bone Miner Metab       Date:  2010-11-10       Impact factor: 2.626

4.  CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway.

Authors:  I Villa; E Mrak; A Rubinacci; F Ravasi; F Guidobono
Journal:  Am J Physiol Cell Physiol       Date:  2006-04-12       Impact factor: 4.249

5.  Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.

Authors:  J Cheung; Y T Mak; S Papaioannou; B A J Evans; I Fogelman; G Hampson
Journal:  J Endocrinol       Date:  2003-06       Impact factor: 4.286

6.  Human osteoblast-like cell proliferation induced by calcitonin-related peptides involves PKC activity.

Authors:  I Villa; C Dal Fiume; A Maestroni; A Rubinacci; F Ravasi; F Guidobono
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-11-12       Impact factor: 4.310

7.  Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling.

Authors:  M Hukkanen; Y T Konttinen; S Santavirta; P Paavolainen; X H Gu; G Terenghi; J M Polak
Journal:  Neuroscience       Date:  1993-06       Impact factor: 3.590

8.  Are OPG and RANKL involved in human fracture healing?

Authors:  Julia Köttstorfer; Anita Thomas; Markus Gregori; Mathias Kecht; Georg Kaiser; Stefan Eipeldauer; Kambiz Sarahrudi
Journal:  J Orthop Res       Date:  2014-09-12       Impact factor: 3.494

9.  CGRP may regulate bone metabolism through stimulating osteoblast differentiation and inhibiting osteoclast formation.

Authors:  Haitao He; Jianshen Chai; Shengfu Zhang; Linlin Ding; Peng Yan; Wenjun Du; Zhenzhou Yang
Journal:  Mol Med Rep       Date:  2016-03-21       Impact factor: 2.952

10.  Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein.

Authors:  Qiang Fu; Robert L Jilka; Stavros C Manolagas; Charles A O'Brien
Journal:  J Biol Chem       Date:  2002-10-02       Impact factor: 5.157

View more
  1 in total

Review 1.  The roles of miRNA, lncRNA and circRNA in the development of osteoporosis.

Authors:  Yang Yang; Wang Yujiao; Wang Fang; Yuan Linhui; Guo Ziqi; Wei Zhichen; Wang Zirui; Wang Shengwang
Journal:  Biol Res       Date:  2020-09-16       Impact factor: 5.612

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.